ASEAN-6
Home to over half a billion people, the ASEAN region constitutes the eighth largest economy in the world. With pharmaceutical sales projected to exceed $148.3 billion by 2027, it’s an increasingly attractive and dynamic growth market for pharma manufacturers.
But with pharmaceutical market researchers being subjected to ever tighter budgets and timelines, conducting research in all ASEAN markets is rarely a viable option. A common question amongst our clients interested in leveraging opportunities within the ASEAN markets is ‘if I can research only one ASEAN market for my product, how do I go about choosing one?’ A seemingly straightforward question, yet one which is actually quite difficult to answer.
Download the infographic.
Other insights.
Jump to a slide with the slide dots.
China – How to strategize and win in the world’s fastest changing healthcare market
In this paper, our experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma.
Read moreChina invests in building Biotech
The advancement of treatment for HIV since the 1980s when the epidemic began has been rapid, but beyond the pill, the reduction of HIV infection.
Read moreInfographic: Emerging markets: Our experience and expertise
Find out about our team of emerging market experts with this infographic outlining our experience and expertise across a vast number of regions.
Read moreSign up to receive Rapport.
Rapport is our monthly newsletter where we share our latest expertise and experience.